Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,698Revenue $M91.1Net Margin (%)-188.4Z-Score8.1
Enterprise Value $M6,739EPS $-0.4Operating Margin %-160.0F-Score3
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-187.7Higher ROA y-yY
Price/Book7.610-y EBITDA Growth Rate %9.0Quick Ratio1.5Cash flow > EarningsY
Price/Sales68.75-y EBITDA Growth Rate %39.8Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-12.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-19.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M452ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKMario Gabelli 2014-09-30 Reduce$8.19 - $9.46
($8.79)
$ 14.8341%Reduce -26.67%11,000
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 14.8341%Reduce -84.24%235,600
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 14.8341%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 14.8346%New holding745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 14.8373%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 14.8384%Add 962.00%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 14.8386%Reduce -90.00%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-21Buy5,700$14.32.52view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-17Buy19,800$14.292.59view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-16Buy10,800$14.630.21view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-10Buy7,200$14.223.09view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-09Buy12,600$14.262.81view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-08Buy10,800$14.262.81view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-07Buy5,400$14.292.59view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-06Buy10,800$14.213.17view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-02Buy3,600$14.342.23view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2015-04-01Buy9,000$14.143.68view

Press Releases about OPK :

    Quarterly/Annual Reports about OPK:

    News about OPK:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: NRZ, BH, OPK, DRI, CLMS Apr 17 2015 
    Weekly CEO Buys Highlight: PHII, RHP, OPK, VNR, LUB Apr 02 2015 
    Weekly CEO Buys Highlight: S, OPK, CAPL, CLF, MOSY Mar 09 2015 
    Recent Stocks Impacted By Insider Buying Feb 21 2015 
    Weekly CEO Buys Highlight: HES, GDOT, BH, CUBI, OPK Feb 09 2015 
    Weekly CEO Buys Highlight: OPK, TCBI, SWN, EGBN, AZZ Jan 28 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
    Weekly CEO Buys Highlight: LTRPA, ENH, BH, OPK, CPTA Dec 28 2014 
    Self-Made Billionaire Believes Drone Aviation Holding Corp. (DRNE) Will Be 2015's Best-Performing Dr Dec 16 2014 

    More From Other Websites
    5 Stocks With Big Insider Buying Apr 22 2015
    Lions Gate, Coty And Other Stocks Insiders Have Been Buying Apr 21 2015
    OPKO Announces Publication of ProtecT Study Using Kallikrein Biomarkers in 4Kscore Test Apr 21 2015
    OPKO Announces Publication of ProtecT Study Using Kallikrein Biomarkers in 4Kscore Test Apr 21 2015
    MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and OPKO Health Apr 08 2015
    MabVax Therapeutics Announces Closing of Financing Apr 06 2015
    OPKO HEALTH, INC. Files SEC form 8-K, Other Events Apr 02 2015
    Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes Apr 01 2015
    Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes Apr 01 2015
    OPKO HEALTH, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities Mar 30 2015
    Phase 3 Data Supporting Rayaldee™ As a Treatment for Secondary Hyperparathyroidism in Chronic... Mar 27 2015
    Opko Health Inc. (OPK), Pacific DataVision, Inc. (PDVW), LGI Homes Inc (LGIH): Three Stocks with... Mar 23 2015
    OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources Mar 23 2015
    OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources Mar 23 2015
    OPKO HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 19 2015
    OPKO Lab Receives Accreditation From College of American Pathologists Mar 18 2015
    OPKO Lab Receives Accreditation From College of American Pathologists Mar 18 2015
    Cocrystal Pharma to Appoint Jeffrey Meckler as Interim Chief Executive Officer Mar 12 2015
    OPKO HEALTH, INC. Financials Mar 06 2015
    Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney... Mar 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK